BACKGROUND: Present angiotensin-converting-enzyme inhibitor treatment fails to prevent progression of non-diabetic renal disease. We aimed to assess the efficac...
作者：国际循环网 发布于：2004-08-24
BACKGROUND: Most cardiovascular events associated with hypertension are complications of atherosclerosis. Some antihypertensive agents influence experimental mo...
作者：ZanchettiA，BondMG，HennigM 发布于：2004-08-24
BACKGROUND: Calcium antagonists are a first-line treatment for hypertension. The effectiveness of diltiazem， a non-dihydropyridine calcium antagonist， in redu...
作者：国际循环网 发布于：2004-08-10
BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by physicians in doses lower than the large doses that have been shown to re...
BACKGROUND: Beta-blocking agents improve functional status and reduce morbidity in mild-to-moderate heart failure， but it is not known whether they produce suc...
BACKGROUND: The ELITE study showed an association between the angiotensin II antagonist losartan and an unexpected survival benefit in elderly heart-failure pat...
专家视角丨高血压管理新篇：余静教授202..
心房颤动患者和动脉粥样硬化患者磁共振..
ESC专访｜郭豫涛教授解析mAFA扩展试验结..
波兰国家注册数据：药物涂层球囊治疗冠..
京公网安备 11010502033353号 增值电信业务经营许可证:京ICP证150541号
